Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Multiple Sclerosis

  Free Subscription


1 Ann Neurol
1 Clin Exp Immunol
1 J Immunol
1 J Neurosci Res
1 Mult Scler

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Neurol

  1. MOCCIA M, Prados F, Filippi M, Rocca MA, et al
    Longitudinal spinal cord atrophy in multiple sclerosis using the generalised boundary shift integral.
    Ann Neurol. 2019 Aug 6. doi: 10.1002/ana.25571.
    PubMed     Text format     Abstract available

    Clin Exp Immunol

  2. RUIZ-ARGUELLES GJ, Olivares-Gazca JC, Olivares-Gazca M, Leon-Pena AA, et al
    Self-reported changes in the expanded disability status scale (EDSS) score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center.
    Clin Exp Immunol. 2019 Aug 8. doi: 10.1111/cei.13358.
    PubMed     Text format     Abstract available

    J Immunol

  3. FRAUSSEN J, Marquez S, Takata K, Beckers L, et al
    Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD(-)CD27(-) Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.
    J Immunol. 2019 Aug 7. pii: jimmunol.1801236. doi: 10.4049/jimmunol.1801236.
    PubMed     Text format     Abstract available

    J Neurosci Res

  4. YAZDI A, Ghasemi-Kasman M, Javan M
    Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process.
    J Neurosci Res. 2019 Aug 5. doi: 10.1002/jnr.24509.
    PubMed     Text format     Abstract available

    Mult Scler

  5. PISA M, Ratti F, Vabanesi M, Radaelli M, et al
    Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
    Mult Scler. 2019 Aug 8:1352458519861603. doi: 10.1177/1352458519861603.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.